Ophthalmic Emulsion ( DrugBank: - )

---

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
51	全身性強皮症	1
53	シェーグレン症候群	1

51. 全身性強皮症

---

臨床試験数 : 523 /  薬物数 : 608 - (DrugBank : 156) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 215

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00025818 (ClinicalTrials.gov)	May 2001	26/10/2001	Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome		Keratoconjunctivitis Sicca;Sjogren's Syndrome;Lupus Erythematosus, Systemic;Arthritis, Rheumatoid;Scleroderma, Systemic	Drug: Ophthalmic Emulsion	Allergan	NULL	Completed	18 Years	N/A	Both	290	Phase 3	United States

53. シェーグレン症候群

---

臨床試験数 : 283 /  薬物数 : 320 - (DrugBank : 101) / 標的遺伝子数 : 56 - 標的パスウェイ数 : 181

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00025818 (ClinicalTrials.gov)	May 2001	26/10/2001	Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome		Keratoconjunctivitis Sicca;Sjogren's Syndrome;Lupus Erythematosus, Systemic;Arthritis, Rheumatoid;Scleroderma, Systemic	Drug: Ophthalmic Emulsion	Allergan	NULL	Completed	18 Years	N/A	Both	290	Phase 3	United States